首页 › 基金 › FARALLON CAPITAL MANAGEMENT, L.L.C. › AGIO
FARALLON CAPITAL MANAGEMENT, L.L.C. 对 AGIO 的持仓历史
AGIOS PHARMACEUTICALS INC · 医疗保健
FARALLON CAPITAL MANAGEMENT, L.L.C. 在 Q3 2026 的 13F 申报中披露持有 AGIO(AGIOS PHARMACEUTICALS INC)5,939,400 股,市值约 US$197.5M,约占其申报组合的 0.87%,在其申报持仓中市值排名第 29 位。 FARALLON CAPITAL MANAGEMENT, L.L.C. 最近 13 个申报季度中有 13 个季度披露了 AGIO 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
FARALLON CAPITAL MANAGEMENT, L.L.C. 对 AGIO 的持仓演变
FARALLON CAPITAL MANAGEMENT, L.L.C. 于 Q3 2023 首次披露 AGIO 持仓:2,750,829 股(约 US$68.1M)。 该持仓在 Q3 2024 达到峰值 5,660,866 股,市值约 US$251.5M。 在 13 次申报中,FARALLON CAPITAL MANAGEMENT, L.L.C. 6 次增持、1 次减持、5 次保持不变。 最近一期申报(Q3 2026)显示持股 5,939,400 股、市值约 US$197.5M。 持仓曾出现大幅变动:Q4 2023 增持约 52% (随后一个季度股价上涨 31%)、Q1 2024 增持约 34% (随后一个季度股价上涨 47%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 2.75M | $68.08M | 新进 |
| Q4 2023 | 4.17M | $92.81M | 增持 |
| Q1 2024 | 5.59M | $163.47M | 增持 |
| Q2 2024 | 5.65M | $243.82M | 增持 |
| Q3 2024 | 5.66M | $251.51M | 持有 |
| Q4 2024 | 5.67M | $186.46M | 持有 |
| Q1 2025 | 5.70M | $167.02M | 持有 |
| Q2 2025 | 5.77M | $191.83M | 增持 |
| Q3 2025 | 5.78M | $232.05M | 持有 |
| Q4 2025 | 5.16M | $140.44M | 减持 |
| Q1 2026 | 5.68M | $192.29M | 增持 |
| Q2 2026 | 5.92M | $219.59M | 增持 |
| Q3 2026 | 5.94M | $197.49M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 AGIO 与 13F 数据
AGIO(AGIOS PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 AGIO,申报仓位最大的包括:法拉龙资本管理 (US$219.6M), Lynx1 Capital Management LP (US$126.5M), ARMISTICE CAPITAL, LLC (US$85.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 AGIO 的基金
- 法拉龙资本管理 5.92M 股 · $219.59M · Q2 2026
- Lynx1 Capital Management LP 3.41M 股 · $126.51M · Q2 2026
- ARMISTICE CAPITAL, LLC 2.58M 股 · $85.72M · Q3 2026
- Erste Asset Management GmbH 1.80M 股 · $60.10M · Q3 2026
- ADAR1 Capital Management, LLC 1.14M 股 · $37.89M · Q3 2026
- Foresite Capital Management VI LLC 785.00K 股 · $29.13M · Q2 2026
更多关于 FARALLON CAPITAL MANAGEMENT, L.L.C.
常见问题
How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held AGIO?
FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed AGIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in AGIO?
As of Q3 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 5.94M shares of AGIO (AGIOS PHARMACEUTICALS INC), valued at $197.49M, representing 0.87% of its reported portfolio and ranking #29.
Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling AGIO?
In the latest 13F filing (Q3 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. held unchanged its position in AGIO. The position peaked in Q3 2024 at 5.66M shares.
Which other funds hold AGIO?
Other major institutional holders of AGIO include 法拉龙资本管理, Lynx1 Capital Management LP, ARMISTICE CAPITAL, LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.